SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001415889-16-006544
Filing Date
2016-07-20
Accepted
2016-07-20 14:32:23
Documents
1
Period of Report
2016-07-20
Effectiveness Date
2016-07-20

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE SCHEDULE 14A fpmidef14a_july2016.htm DEF 14A 190583
  Complete submission text file 0001415889-16-006544.txt   191763
Mailing Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042
Business Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042 973-744-1565
FLUOROPHARMA MEDICAL, INC. (Filer) CIK: 0001402785 (see all company filings)

IRS No.: 208325616 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 333-147193 | Film No.: 161775181
SIC: 2835 In Vitro & In Vivo Diagnostic Substances